Analysis of Insulin Sensitivity in Adipose Tissue of Patients with Primary Aldosteronism
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The objective of the study was to assess the effect of high aldosterone levels on insulin sensitivity of adipose tissue in humans. METHODS: Visceral adipose tissue (VAT) was obtained from patients with aldosterone-producing adenoma (APA; n=14) and, as controls, nonfunctioning adenoma (NFA; n=14) undergoing laparoscopic adrenalectomy. Homeostasis model assessment index was higher and potassium was lower in APA than NFA (P<0.05). Immunohistochemistry, Western blotting, and real-time PCR were used to detect and quantify mineralocorticoid receptor (MR) expression. Transcript levels of peroxisome proliferative-activated receptor-gamma, insulin receptor, glucose transporter 4, insulin receptor substrate-1 and -2, leptin, adiponectin, IL-6, monocyte chemoattractant protein-1, glucocorticoid receptor (GR)-alpha, 11beta-hydroxysteroid dehydrogenase (HSD11B) type 1, and HSD11B2 were quantified. The effect of increasing aldosterone concentrations on 2-deoxy-[3H]d-glucose uptake was tested in human sc abdominal adipocytes. RESULTS: Expression of MR was demonstrated in VAT, with no difference between APA and NFA as to mRNA levels of MR, GRalpha, HSD11B1, and glucose metabolism and inflammation factors. In cultured adipocytes, basal and insulin-stimulated glucose uptake were unaffected by 1-100 nM (normal/hyperaldosteronism) and impaired only by much higher, up to 10 microM, aldosterone concentrations. The impairment was prevented by RU486 but not by eplerenone. CONCLUSIONS: Gene expression of insulin signaling/inflammatory molecules was similar in VAT of APA and NFA patients, not supporting an effect of aldosterone excess on insulin sensitivity of adipose tissues. Only at pharmacological concentrations and through GR activation, aldosterone reduced glucose uptake in adipocytes. Insulin resistance in primary aldosteronism might occur in compartments other than fat and/or depend on concurrent environmental factors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Prevalence and Characteristics of the Metabolic Syndrome in Primary Aldosteronism
Fallo, F., Veglio, F., Bertello, C., Sonino, N., Della Mea, P., Ermani, M., Rabbia, F., Federspil, G., & Mulatero, P. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1733 · Cited by 372 · cited 2×
“Criteria for the diagnosis of primary aldosteronism due to APA were as previously described (1).”
MethodSelf-citationPivotal role of the mineralocorticoid receptor in corticosteroid‐induced adipogenesis
Caprio, M., Fève, B., Claës, A., Viengchareun, S., Lombès, M., & Zennaro, M.-C. (2007) · The FASEB Journal · doi:10.1096/fj.06-7970com · Cited by 337 · cited 1×
“Whereas MR is present in murine preadipocytes and differentiated adipocytes (14), scarce data are available on human adipose tissue (15).”
BackgroundSelf-citationBujalska, I. J., Kumar, S., Hewison, M., & Stewart, P. M. (1999) · Endocrinology · doi:10.1210/endo.140.7.6868 · Cited by 254
Risk Factors and Long-Term Follow-Up of Adrenal Incidentalomas1
Barzon, L., Scaroni, C., Sonino, N., Fallo, F., Paoletta, A., & Boscaro, M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5444 · Cited by 254
Self-citationPagano, C., Pilon, C., Calcagno, A., Urbanet, R., Rossato, M., Milan, G., Bianchi, K., Rizzuto, R., Bernante, P., Federspil, G., et al. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0768 · Cited by 210
Self-citationThe Nongenomic Actions of Aldosterone
Funder, J. W. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0004 · Cited by 200
Review article: adipocytokines and insulin resistance
VETTOR, R., MILAN, G., ROSSATO, M., & FEDERSPIL, G. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02587.x · Cited by 185
Self-citationConnell, J. M. C., MacKenzie, S. M., Freel, E. M., Fraser, R., & Davies, E. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0030 · Cited by 182 · cited 1×
“Aldosterone excess in primary aldosteronism is related to impaired glucose homeostasis and insulin resistance, leading to increased prevalence of metabolic syndrome (1–3) and a high rate of cardiovascular events (4).”
BackgroundDevelopment of a Panel of Monoclonal Antibodies against the Mineralocorticoid Receptor
Gomez-Sanchez, C. E., de Rodriguez, A. F., Romero, D. G., Estess, J., Warden, M. P., Gomez-Sanchez, M. T., & Gomez-Sanchez, E. P. (2006) · Endocrinology · doi:10.1210/en.2005-0860 · Cited by 182
Cited by
The Role of the Renin-Angiotensin-Aldosterone System in Obesity-Related Renal Diseases
Rüster, C., & Wolf, G. (2013) · Seminars in Nephrology · doi:10.1016/j.semnephrol.2012.12.002 · Cited by 189
The renin–angiotensin–aldosterone system and glucose homeostasis
Luther, J. M., & Brown, N. J. (2011) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.07.006 · Cited by 185
Hanslik, G., Wallaschofski, H., Dietz, A., Riester, A., Reincke, M., Allolio, B., Lang, K., Quack, I., Rump, L. C., Willenberg, H. S., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0450 · Cited by 155
Ott, V., Benedict, C., Schultes, B., Born, J., & Hallschmid, M. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01490.x · Cited by 139
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism
Marzolla, V., Armani, A., Zennaro, M., Cinti, F., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.011 · Cited by 143
Self-citationEffects of aldosterone on insulin sensitivity and secretion
Luther, J. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.08.016 · Cited by 114
The Role of Aldosterone in the Metabolic Syndrome
Briet, M. B., & Schiffrin, E. L. (2011) · Current Hypertension Reports · doi:10.1007/s11906-011-0182-2 · Cited by 103
Impact of Glucocorticoid Excess on Glucose Tolerance: Clinical and Preclinical Evidence
Pasieka, A., & Rafacho, A. (2016) · Metabolites · doi:10.3390/metabo6030024 · Cited by 90
Faulkner, J., Bruder-Nascimento, T. B., & de Chantemèle, E. J. B. (2017) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000384 · Cited by 91
Feraco, A., Armani, A., Mammi, C., Fabbri, A., Rosano, G. M. C., & Caprio, M. (2013) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2013.02.012 · Cited by 60
Bruder-Nascimento, T. B., Silva, M. A. B., & Tostes, R. C. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-90 · Cited by 55
Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
Jing, F., Mogi, M., & Horiuchi, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.005 · Cited by 58
Links between aldosterone excess and metabolic complications: A comprehensive review
Bothou, C., Beuschlein, F., & Spyroglou, A. (2019) · Diabetes & Metabolism · doi:10.1016/j.diabet.2019.02.003 · Cited by 57
Inflammation and Fibrosis in Perirenal Adipose Tissue of Patients With Aldosterone-Producing Adenoma
Wu, C., Zhang, H., Zhang, J., Xie, C., Fan, C., Zhang, H., Wu, P., Wei, Q., Tan, W., Xu, L., et al. (2018) · Endocrinology · doi:10.1210/en.2017-00651 · Cited by 52
Boscaro, M., Giacchetti, G., & Ronconi, V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2012.06597.x · Cited by 56
Self-citationCerebro-Cardiovascular Risk, Target Organ Damage, and Treatment Outcomes in Primary Aldosteronism
Lin, X., Ullah, M. H. E., Xiong, W., Xu, F., Shan, S., Lei, L.-M., Yuan, L., & Liu, J. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.798364 · Cited by 45
Gorini, S., Marzolla, V., Mammi, C., Armani, A., & Caprio, M. (2018) · Biomolecules · doi:10.3390/biom8030096 · Cited by 40
Faulkner, J., & de Chantemèle, E. J. B. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.09.003 · Cited by 32
Genes implicated in insulin resistance are down-regulated in primary aldosteronism patients
Williams, T. A., Monticone, S., Urbanet, R., Bertello, C., Giraudo, G., Vettor, R., Fallo, F., Veglio, F., & Mulatero, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.007 · Cited by 25
Self-citationKuhn, E., Bourgeois, C., Keo, V., Viengchareun, S., Muscat, A., Méduri, G., Menuet, D. L., Fève, B., & Lombès, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00323.2013 · Cited by 26
Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism
Grewal, S., Fosam, A., Chalk, L., Deven, A., Suzuki, M., Correa, R. R., Blau, J. E., Demidowich, A. P., Stratakis, C. A., & Muniyappa, R. (2021) · Endocrine · doi:10.1007/s12020-020-02576-y · Cited by 20
Lefranc, C., Friederich‐Persson, M., Foufelle, F., Cat, A. N. D., & Jaisser, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062881 · Cited by 22
Adipocyte Mineralocorticoid Receptor
Infante, M., Armani, A., Marzolla, V., Fabbri, A., & Caprio, M. (2018) · Vitamins and hormones · doi:10.1016/bs.vh.2018.10.005 · Cited by 21
Jadhav, A., & Ndisang, J. F. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.529 · Cited by 19
Er, L., Lin, M.-C., Tsai, Y., Hsiao, J., Yang, C.-Y., Chang, C., Peng, K., Chueh, S., & Wu, V. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2019-001153 · Cited by 18
The mineralocorticoid receptor: a new player controlling energy homeostasis
Kuhn, E., & Lombès, M. (2013) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2013-0033 · Cited by 10
Then, C., Ritzel, K., Herder, C., Then, H. L., Sujana, C., Heier, M., Meisinger, C., Peters, A., Köenig, W., Rathmann, W., et al. (2022) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002558 · Cited by 9
Chiang, J., Chen, C., Tseng, F., Chi, Y., Huang, K., & Yang, W. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0175-6 · Cited by 9
The McKittrick–Wheelock syndrome: a rare cause of curable diabetes
Challis, B., Lim, C. T., Cluroe, A. D., Cameron, E. A., & O’Rahilly, S. (2016) · Endocrinology Diabetes and Metabolism Case Reports · doi:10.1530/edm-16-0013 · Cited by 8
Adrenal–adipose tissue crosstalk in health and disease
Jiang, M., Stifel, U., Blüher, M., Lefèbvre, H., Bornstein, S. R., & Bechmann, N. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf252 · Cited by 4
Adipose tissue signaling in aldosterone-producing adenomas: paracrine and endocrine effects
Kloock, S., Kagan, L., Ziegler, C. G., Srivastava, M., Tönjes, A., Rayes, N., Schlegel, N., Geiger, N., Blüher, M., Faßnacht, M., et al. (2025) · European Journal of Endocrinology · doi:10.1093/ejendo/lvaf190 · Cited by 3
Insulin signaling in adipose tissue of patients with primary aldosteronism
Urbanet, R., Pilon, C., Giorgino, F., Vettor, R., & Fallo, F. (2011) · Journal of Endocrinological Investigation · doi:10.1007/bf03347035 · Cited by 3
Self-citationTakeda, Y., Demura, M., Kometani, M., Karashima, S., Aono, D., Konishi, S., Horike, S., Meguro‐Horike, M., Yoneda, T., & Takeda, Y. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0103 · Cited by 2
Metabolic syndrome and primary aldosteronism: time for reappraisal?
Fallo, F., & Sonino, N. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.76 · Cited by 2
Self-citationComplicanze cardiometaboliche e renali nell’iperaldosteronismo primario
Giacchetti, G., Ronconi, V., Giovannini, L., Ceccoli, L., di Tizio, V., Turchi, F., & Boscaro, M. (2011) · L Endocrinologo · doi:10.1007/bf03344805
Self-citationVers l’identification de nouveaux effets métaboliques du récepteur des minéralocorticoïdes
Fève, B. (2012) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(12)70395-4
Prevention of Adverse Metabolic Consequences of Adipocyte Dysfunction Using MR Antagonists
Caprio, M., Marzolla, V., & Armani, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-805421-5.00007-0
Impact du récepteur minéralocorticoïde sur le métabolisme énergétique
Kuhn, E. (2014) · theses.fr (ABES) · doi:10.70675/2f394ed5z2580z483cz8b59zdebe5eeab26b
Metadata
- Authors
- Urbanet, R., Pilon, C., Calcagno, A., Peschechera, A., Hubert, E.-L., Giacchetti, G., Gomez-Sanchez, C., Mulatero, P., Toffanin, M., Sonino, N., Zennaro, M.-C., Giorgino, F., Vettor, R., & Fallo, F.
- Affiliations
- University of Padua (IT)
- University of Bari Aldo Moro (IT)
- Inserm (FR)
- Division of Endocrinology (G.G.), Universitv of Ancona, 60126 Ancona, Italy;
- Endocrinology Section (C.G.-S.), G. V. (Sonny) Montgomery Veterans Affairs Medical Center and University of Mississippi Medical Center, Jackson, Mississippi 39216;
- University of Turin (IT)
- Corresponding author
- Fallo, Francesco
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2010-08-01
- Volume
- 95
- Issue
- 8
- Pages
- 4037-4042
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2053759435
- Semantic Scholar
- 642bd190462c8cab49a77d5f6a33b90ede1b42d0
- Cited by
- 38
- References
- 21
- Citations by year
- 2025: 2 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 2 · 2019: 1 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 2 · 2014: 2 · 2013: 4 · 2012: 5
- FWCI
- 3.87
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
- CINECA IRIS Institutional Research Information System (University of Bari Aldo Moro) (submittedVersion, other-oa)
- Padua Research Archive (University of Padova) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- primary aldosteronism, insulin sensitivity, visceral adipose tissue, aldosterone, aldosterone-producing adenoma, mineralocorticoid receptor, glucocorticoid receptor, insulin resistance, glucose uptake, adipocytes, 11β-hydroxysteroid dehydrogenase, RU486, eplerenone, adipose tissue inflammation, insulin signaling
- MeSH terms
- Adrenal Cortex Neoplasms, Adrenocorticotropic Hormone, Aldosterone, Analysis of Variance, Female, Humans, Hydrocortisone, Hyperaldosteronism, Immunohistochemistry, Insulin, Insulin Resistance, Male, Renin, RNA, Messenger, Blotting, Western, Receptors, Mineralocorticoid, Adrenocortical Adenoma, Reverse Transcriptase Polymerase Chain Reaction, Intra-Abdominal Fat, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.